Allscripts will offer users EHR-integrated multifactor authentication to improve identity proofing when electronically prescribing controlled substances.
The health IT company partnered with identity proofing services provider ID.me to enable providers to verify their identity online in compliance with Drug Enforcement Administration (DEA) regulations.
“With secure digital identity, malicious actors will have a much more difficult time perpetrating opioid abuse,” said ID.me CEO and founder Blake Hall.
“Our solution conforms to rigorous federal requirements for prescribing controlled substances, yet we have taken great care to ensure the process is also accessible for providers so they can spend as much time as possible caring for patients,” Hall continued.
Users will have access to the new feature starting in march 2019. Healthcare providers will be required by federal law to completely stop using paper processes to prescribe controlled substances and transition to only using electronic prescribing for controlled substances (EPCS) EHR functionality after January 2021.
The new feature will allow Allscripts prescribers to verify their identity and validate their credentials, including their DEA and NPI identifiers. Registration for multifactor authentication is conducted through an online self-serve flow or over video chat with an ID.me call center representative.
IDme’s EPCS solution complies with the newest NIST Identity Assurance Level 2 and Authenticator Assurance Level 2 standards. Meeting NIST standards is necessary for prescribing certain controlled substances such as opioids.
These standards are being recommended as part of the forthcoming Trusted Exchange Framework and Common Agreement (TEFCA). TEFCA is designed to define health IT standards for health data exchange and interoperability between different healthcare systems and health IT systems. Participation in TEFCA is voluntary.
ID.me is working to simplify the identity proofing process and enable individuals to securely share their identity online. The IT company is currently in the process of developing a digital identity network where users will only need to verify their identity once across any organizations where ID.me is accepted.
Allscripts currently connects 2,500 hospitals and 300,000 healthcare providers across the country.
This most recent effort is the latest in a string of new EHR functionality from the health IT company intended to streamline and improve prescribing processes for providers.
In October 2018, Allscripts partnered with substance use disorder prevention and management solutions provider Appriss Health to allow users to access prescription drug monitoring program (PDMP) information at the point of care.
Allscripts users will also gain access to Appriss Health’s NarxCare platform through Allscripts ePrescribe, Allscripts Professional EHR, Allscripts TouchWorks EHR, Practice Fusion EHR, and Allscripts Sunrise EHR.
The health IT company will use Appriss Health’s PMP Gateway to offer clinicians EHR-integrated access to patient prescription information, data analytics tools, and other resources to support clinical decision-making, boost patient health outcomes, and promote safe prescribing practices.
The deployment model allows providers to automatically integrate NarxCare into their EHR systems when they sign up and update their EHR or ePrescribe version.
“Our vision at Allscripts is to build open, interoperable connected communities of care,” said Allscripts Payer & Life Sciences CEO Tom Langan.
“As the opioid crisis grows, changes and continues to devastate the U.S., we are aggressively moving to provide our clinicians with a solution that offers objective information and insights into a patient’s risk for drug misuse, abuse, overdose, and death, so patients can be provided with the most effective and appropriate care,” Langan continued.
Reducing the administrative burden associated with PDMP use can help to cut down on the amount of time providers spend interacting with their EHR systems and improve physician satisfaction with EHR use.